In a First, FDA Grants Full Approval to Anti-Amyloid Drug for Alzheimer’s
On Thursday, the Food and Drug Administration made a decision that’s likely to have a major impact on the landscape of Alzheimer’s disease research. The agency issued a full-throated traditional…